TABLE 2.
Age group (yr)a | No. (%) of subjects from which BKV DNA was amplified inb:
|
No. (%) of subjects from which JCV DNA was amplified inb:
|
||||||
---|---|---|---|---|---|---|---|---|
1 trial | 2 trials | 3 trials | Total | 1 trial | 2 trials | 3 trials | Total | |
0-9 | 3 | 3 | 6 | 12 (24) | 0 | 0 | 5 | 5 (10) |
10-19 | 1 | 3 | 4 | 8 (16) | 0 | 0 | 8 | 8 (16) |
20-29 | 1 | 1 | 5 | 7 (14) | 0 | 0 | 19 | 19 (38) |
30-39 | 1 | 5 | 5 | 11 (22) | 0 | 0 | 26 | 26 (52) |
40-49 | 2 | 3 | 7 | 12 (24) | 0 | 0 | 29 | 29 (58) |
50-59 | 2 | 2 | 11 | 15 (30) | 1 | 0 | 28 | 29 (58) |
60-69 | 1 | 2 | 13 | 16 (32) | 0 | 1 | 32 | 33 (66) |
70-79 | 1 | 4 | 14 | 19 (38) | 0 | 1 | 34 | 35 (70) |
80-89 | 1 | 5 | 16 | 22 (44) | 0 | 0 | 36 | 36 (72) |
Total | 13 | 28 | 81 | 122 (27) | 1 | 2 | 217 | 220 (49) |
Each group contained 50 subjects, and each subject gave a single urine sample.
Amplification of the typing region of BKV DNA and the IG region of JCV DNA was repeated three times for each sample.